🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To estimate parameters related to clinical outcomes in a real-world seeting...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-07-23
Trial ID
NCT06376084
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
This study will treat patients with advanced NSCLC who have already receive...
Status
Completed
Location
Research Site
Start Date
2013-03-04
Trial ID
NCT01802632
Treatments Being Tested
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Status
Recruiting
Location
Maryland Oncology Hematology
Start Date
2023-07-24
Trial ID
NCT05748834
The Tissue Repository will search for cases, pull slides, Paraffin-embedded...
Status
Withdrawn
Location
University of New Mexico
Start Date
2005-12
Trial ID
NCT00298064
Treatments Being Tested
This open-label, multicenter, randomized phase II study will evaluate the u...
Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Start Date
2019-03-19
Trial ID
NCT03769103
Treatments Being Tested
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Start Date
2023-11-13
Trial ID
NCT05870579
Treatments Being Tested